BRUKER CORP
Close on Oct 19, 2026
- Market cap
- $8.43B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 2, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 4, 2026 | Before market open | $838.50M | $-0.41 | $0.49 |
| Q1 FY2026 Ended Mar 31, 2026 | May 6, 2026 | Before market open | $823.40M | $0.02 | $0.31 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 12, 2026 | Before market open | $977.20M | $0.10 | $0.59 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 3, 2025 | Before market open | $860.50M | $-0.41 | $0.45 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 21, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 7, 2025 | Before market open | $801.40M | $0.11 | $0.47 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 13, 2025 | Before market open | $979.60M | $0.09 | $0.76 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 5, 2024 | Before market open | $864.40M | $0.27 | $0.60 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 2, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 13, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 4, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Non-GAAP EPSnon-GAAP | FY2026 | $2.10 to $2.15 | Maintained |
| Revenues | FY2026 | $3.54B to $3.57B | Lowered |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Bruker filed with the SEC
Bruker Reports Second Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Announces Second Quarter 2025 Preliminary Results,
Results of operations · EX-99.1 to Form 8-K
Bruker and 10x Genomics Reach Global Settlement of Patent Litigation
Other events · EX-99.1 to Form 8-K
Bruker Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Announces First Quarter 2025 Preliminary Revenue
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
WIRE)-- Bruker Corporation (“Bruker” or the “Company”) (Nasdaq: BRKR) today announced the launch of an underwritten
Material agreement · Other events · EX-99.1 to Form 8-K
Bruker Announces Pricing of Public
Material agreement · Other events · EX-99.2 to Form 8-K
Bruker Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
Regulation FD disclosure · EX-99.1 to Form 8-K
the NanoString Business in an Asset Deal
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Second Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
Other events · EX-99.1 to Form 8-K
Bruker Reports First Quarter 2023 Financial Results
Results of operations · EX-99 to Form 8-K
Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Third Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Bruker Reports Second Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K